Literature DB >> 19779966

Stress-related Epstein-Barr virus reactivation.

Omer Coskun1, Kenan Sener, Selim Kilic, Hakan Erdem, Halil Yaman, Ahmet Bulent Besirbellioglu, Hanefi Cem Gul, Can Polat Eyigun.   

Abstract

Epstein-Barr virus (EBV) remains latent in 90% of the patients following primary infection. The infection might be reactivated due to various stress factors. We, therefore, examined the levels of stress hormones (epinephrine, norepinephrine and cortisol), viral capsid antigen (VCA) immunoglobulin Ig G, VCA IgM, EBV early antigen IgG, Epstein-Barr nuclear antigen (EBNA) IgG, EBNA IgM antibody screening tests and performed EBV polymerized chain reaction (PCR) test and EBV DNA PCR in 100 draftees on their first day of recruitment and at the end of 1 month. Examination of the initial samples revealed that 94 (94%) subjects previously had EBV infection and 6 (6%) were seronegative. Second samples obtained at the end of first month showed that 7 (7.4%) reactivations occurred in 94 subjects who previously had EBV infection (P < 0.001). Two out of six (33.3%) who were initially seronegative had acute infection (P = 0.289). There was no significant difference between the median values of the levels of stress hormones in the initial and second serum and plasma samples. There was a significant difference between the rates of acute infection and reactivation among subjects with elevated cortisol and epinephrine levels in the second samples compared to subjects with normal levels (P < 0.001). No significant difference was determined between the first and second sample hormone levels of all nine subjects whose EBV-DNA turned positive. Routine examinations might not reveal any specific findings since EBV infection often has an asymptomatic course. EBV reactivations should always be kept in mind in patients subject to such stressful conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779966     DOI: 10.1007/s10238-009-0063-z

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  24 in total

1.  Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts.

Authors:  R P Stowe; D L Pierson; A D Barrett
Journal:  Psychosom Med       Date:  2001 Nov-Dec       Impact factor: 4.312

2.  Stress-induced modulation of the immune response to recombinant hepatitis B vaccine.

Authors:  R Glaser; J K Kiecolt-Glaser; R H Bonneau; W Malarkey; S Kennedy; J Hughes
Journal:  Psychosom Med       Date:  1992 Jan-Feb       Impact factor: 4.312

3.  Immunological analyses of U.S. Space Shuttle crewmembers.

Authors:  G R Taylor; L S Neale; J R Dardano
Journal:  Aviat Space Environ Med       Date:  1986-03

4.  Epstein-Barr virus specific salivary antibodies as related to stress caused by examinations.

Authors:  O Sarid; O Anson; A Yaari; M Margalith
Journal:  J Med Virol       Date:  2001-06       Impact factor: 2.327

5.  Evaluation of the Wampole Laboratories ELISA-based assay for Epstein-Barr virus serology.

Authors:  Mark K Fung; Kathy T Mordarski; Sharon A Bader; Ann M Gronowski
Journal:  Clin Chim Acta       Date:  2002-05-07       Impact factor: 3.786

Review 6.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition.

Authors:  S F Maier; L R Watkins
Journal:  Psychol Rev       Date:  1998-01       Impact factor: 8.247

7.  Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry.

Authors:  Suzanne C Segerstrom; Gregory E Miller
Journal:  Psychol Bull       Date:  2004-07       Impact factor: 17.737

8.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

Authors:  J F Jones; S Shurin; C Abramowsky; R R Tubbs; C G Sciotto; R Wahl; J Sands; D Gottman; B Z Katz; J Sklar
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

9.  Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.

Authors:  Barbara C Gärtner; Ralf D Hess; Dirk Bandt; Alexander Kruse; Axel Rethwilm; Klaus Roemer; Nikolaus Mueller-Lantzsch
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.

Authors:  Claudia C Bauer; Stephan W Aberle; Theresia Popow-Kraupp; Magdalena Kapitan; Hanns Hofmann; Elisabeth Puchhammer-Stöckl
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327

View more
  9 in total

1.  Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.

Authors:  O Coşkun; E Yazici; F Şahiner; A Karakaş; S Kiliç; M Tekin; C Artuk; L Yamanel; B A Beşirbellioğlu
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-07-19       Impact factor: 0.840

2.  A corticoid-sensitive cytokine release assay for monitoring stress-mediated immune modulation.

Authors:  M Feuerecker; W Mayer; I Kaufmann; M Gruber; F Muckenthaler; B Yi; A P Salam; J Briegel; G Schelling; M Thiel; A Choukèr
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

3.  Herpesviruses and their genetic diversity in the blood virome of healthy individuals: effect of aging.

Authors:  Arttu Autio; Jalmari Kettunen; Tapio Nevalainen; Bryn Kimura; Mikko Hurme
Journal:  Immun Ageing       Date:  2022-03-12       Impact factor: 6.400

4.  Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study.

Authors:  Delphine Casabonne; Yolanda Benavente; Claudia Robles; Laura Costas; Esther Alonso; Eva Gonzalez-Barca; Adonina Tardón; Trinidad Dierssen-Sotos; Eva Gimeno Vázquez; Marta Aymerich; Elias Campo; Gemma Castaño-Vinyals; Nuria Aragones; Marina Pollan; Manolis Kogevinas; Hedy Juwana; Jaap Middeldorp; Silvia de Sanjose
Journal:  Infect Agent Cancer       Date:  2015-02-09       Impact factor: 2.965

5.  Lymphopenia in treatment-naive relapsing multiple sclerosis.

Authors:  Zhi Wei Lim; Elliot Elwood; Hammad Naveed; Ian Galea
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-08-12

6.  Oxidative stress biomarkers are associated with visible clinical signs of a disease in frigatebird nestlings.

Authors:  Manrico Sebastiano; Marcel Eens; Hamada Abd Elgawad; Benoît de Thoisy; Vincent Lacoste; Kévin Pineau; Han Asard; Olivier Chastel; David Costantini
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

Review 7.  Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease.

Authors:  Marshall V Williams; Brandon Cox; Maria Eugenia Ariza
Journal:  Pathogens       Date:  2016-12-28

8.  Two cases of uveitis associated with severe transaminitis during a Rickettsia typhi outbreak in Los Angeles County.

Authors:  Betty A Situ; Susan J Streit; Timothy C Tran; Jim H Nomura; Simon R Bababeygy; Damien C Rodger
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-11

9.  Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection.

Authors:  Jiang Qian; Qinhua Yu; Guoqing Chen; Mingxia Wang; Zhao Zhao; Yueyue Zhang; Liannv Qiu
Journal:  Clin Exp Med       Date:  2020-03-23       Impact factor: 3.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.